LOBAT DANESHVAR-JAHROMI: Open Payments
NPI 1841676889 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$904 in 60 payments from 11 companies in 2025. Trend: 2023 $245 · 2024 $774 · 2025 $904
Food & beverage: $904
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $325 |
| Aimmune Therapeutics, Inc. | 20 | $210 |
| AstraZeneca Pharmaceuticals LP | 3 | $173 |
| Lilly USA, LLC | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Ardelyx, Inc. | 1 | $24 |
| Amgen Inc. | 1 | $23 |
| PFIZER INC. | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
Products named: VOWST, AIRSUPRA, UBRELVY, QULIPTA, SYNTHROID, CREON, MOUNJARO, TRELEGY ELLIPTA.
Industry payments across CA — which companies pay providers there.
